PHARMAIDS PH share price has zoomed 10% and is presently trading at Rs 65.3.
Meanwhile, the BSE HEALTHCARE index is at 44,001.7 (up 0.3%).
Among the top gainers in the BSE HEALTHCARE index today are Procter & Gamble Health (up 5.7%) and GLAND PHARMA (up 2.1%).
MAX HEALTHCARE INSTITUTE (down 1.7%) and FORTIS HEALTHCARE (down 1.2%) are among the top losers today.
Over the last one year, PHARMAIDS PH has moved up from Rs 46.0 to Rs 65.3, registering a gain of Rs 19.3 (up 42.0%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,350.0 to 44,001.7, registering a gain of 60.9% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 230.6%), SUVEN PHARMACEUTICALS (up 131.5%) and Glenmark Pharma (up 131.5%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 78,750.4 .
The top losers among the BSE Sensex today are HDFC Bank (down 0.6%) and Reliance Ind. (down 0.5%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 24,007.0 (up 0.1%). JSW Steel and Hindalco are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 63,591.3 to 78,750.4, registering a gain of 15,159.1 points (up 23.8%).
PHARMAIDS PH net profit fell 133.5% YoY to Rs -31 million for the quarter ended June 2024, compared to a loss of Rs 13 million a year ago. Net sales rose 100.0% to Rs 47 million during the period as against Rs 0 million in April-June 2023.
For the year ended March 2024, PHARMAIDS PH reported 56.7% decrease in net profit to Rs -118 million compared to net loss of Rs 76 million during FY23. Revenue of the company grew 100.0% to Rs 151 million during FY24.
The current Price to earnings ratio of PHARMAIDS PH, based on rolling 12 month earnings, stands at -19.9.
Equitymaster requests your view! Post a comment on "PHARMAIDS PH Gains 10%; BSE HEALTHCARE Index Up 0.3%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!